Aromatic P1 replacements for the highly potent HIV-1 protease inhibitor CRIXIVAN®

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 16, 1996, Pages 1937-1940

  Coburn, Craig A ^a   Young, Mary Beth ^a   Hungate, Randall W ^a   Isaacs, Richard C A ^a   Vacca, Joseph P ^a   Huff, Joel R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030594988     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00345-9     Document Type: Article

References (12)

1. 1. (a) Debouck, C. AIDS Res. Hum. Retrov. 1992, 8, 153.
2. (b) Fairlie, D. P.; West, M. L. Trends Pharm. 1995, 16, 67.
3. 2. Kohl, N. E.; Emini, E. A.; Schlief, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A. F.; Scolnick, E. M.; Sigal, I. S. Proc. Natl. Acad. Sci. U.S.A 1988, 85, 4686.
4. 3. Darke, P. L.; Huff, J. R. Adv. Pharmacol. 1994, 25, 399.
5. 4. Dorsey, B. D.; Levin, R. B.; McDaniel, S. L.; Vacca, J. P.; Guare, J. P.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W. A.; Quintero, J. C.; Lin, J. H.; Chen, I. W.; Holloway, M. K.; Fitzgerald, P. M. D.; Axel, M. G.; Ostovic, D.; Anderson, P. S.; Huff, J. R. J. Med. Chem. 1994, 37, 3443.
6. 1 groups have been shown to be effective surrogates when incorporated into HIV PR inhibitors, see: (a) Kaldor, S. W.; Hammond, M.; Diessman, B. A.; Fritz, J. E.; Crowell, T. A.; Hermann, R. A. Bioorg. Med. Chem. Lett. 1994, 4, 1385;
7. (b) Kaldor, S. W.; Appelt, K.; Fritz, J. E.; Hammond M.; Crowell, T. A.; Baxter, A. J.; Hatch, S. D.; Wiskerchen, M.; Muesing, M. A. Bioorg. Med. Chem. Lett. 1995, 5, 715;
8. (c) Kalish, V. J.; Tatlock, J. H.; Davies, J. F.; Kaldor, S. W.; Dressman, B. A.; Reich, S.; Pino, M.; Nyugen, D.; Apelt, K.; Musick, L.; Wu, B. -W. Bioorg. Med. Chem. Lett. 1995, 5, 727.
9. 6. Askin, D.; Eng, K. K.; Rossen, K.; Purick, R. M.; Wells, K. M.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1994, 35, 673.
10. 7. Eis, M. J.; Wrobel, J. E.; Ganem, B. J. Am. Chem. Soc. 1984, 106, 3693.
11. 1H NMR, MS and elemental analysis.
12. 9. For assay protocol, see: Heimbach, J. C.; Garsky, V. M.; Michelson, S. R.; Dixon, R. A. F.; Sigal, I. S.; Darke, P. L. Biochem. Biophys. Res. Commun. 1989, 264, 955.